FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1812633805> ?p ?o ?g. }

• W1812633805 endingPage "67" @default.
• W1812633805 startingPage "61" @default.
• W1812633805 abstract "OBJECTIVE: Prednisone (PRED) is recommended at discharge to reduce the relapse rate following emergency treatment for an asthmatic attack. However, PRED has systemic side effects. Inhaled anti-inflammatory medications, such as budesonide (BUD), are well tolerated. This study was designed to compare the effectiveness of PRED and BUD on relapse rate. DESIGN: A prospective, randomized, double-blind, double dummy, parallel group design. SETTING: Tertiary referral emergency departments. POPULATION STUDIED: One hundred and eighty-five patients with acute asthma who received standard treatment with bronchodilators and systemic glucocorticosteroids in the emergency department, had a forced expiration volume in 1 s (FEV 1 ) greater than 50% predicted and who were deemed well enough to be discharged from the emergency department. INTERVENTION: Patients were randomized to receive either BUD Turbuhaler 600 µg qid or PRED 40 mg in the morning for seven to 10 days. At discharge and final visit, symptoms, medication use, FEV 1, peak expiratory flow (PEF) and quality of life (QoL) were assessed. Relapse rate to the emergency department during the follow-up was determined by a yes and/or no questionnaire. MAIN RESULTS: The PRED (n=85) and BUD (n=90) treatment groups were comparable at baseline (emergency department discharge) for age (mean ± SD; 27.6±8.5 years and 29.2±8.7 years) and prebronchodilator FEV 1 (1.77±0.79 L and 1.75±0.78 L), respectively. BUD was at least as effective as PRED in preventing a relapse to the hospital; relapse rate was 10 (11.8%) during PRED treatment and nine (10.0%) for BUD treatment (95% CI PRED-BUD, -7.5% to 11.0%). Improvements in FEV 1 , asthma symptoms, PEF and QoL were not significantly different between treatments. CONCLUSIONS: In patients whose acute asthma has been stabilized in the emergency department, high dose BUD may be an alternate to PRED as a follow-up treatment." @default.
• W1812633805 created "2016-06-24" @default.
• W1812633805 creator A5017557589 @default.
• W1812633805 creator A5021494931 @default.
• W1812633805 creator A5023864226 @default.
• W1812633805 creator A5036399848 @default.
• W1812633805 creator A5040448604 @default.
• W1812633805 creator A5044898446 @default.
• W1812633805 creator A5054976871 @default.
• W1812633805 creator A5072289497 @default.
• W1812633805 creator A5078128974 @default.
• W1812633805 date "2000-01-01" @default.
• W1812633805 modified "2023-10-11" @default.
• W1812633805 title "A Randomised Controlled Trial of High Dose, Inhaled Budesonide Versus Oral Prednisone in Patients Discharged from the Emergency Department following an Acute Asthma Exacerbation" @default.
• W1812633805 cites W1525531683 @default.
• W1812633805 cites W174079731 @default.
• W1812633805 cites W1752273282 @default.
• W1812633805 cites W1903161601 @default.
• W1812633805 cites W1964069534 @default.
• W1812633805 cites W1971285143 @default.
• W1812633805 cites W1977761895 @default.
• W1812633805 cites W1979457017 @default.
• W1812633805 cites W2022282092 @default.
• W1812633805 cites W2025446617 @default.
• W1812633805 cites W2052009785 @default.
• W1812633805 cites W2059085963 @default.
• W1812633805 cites W2066815911 @default.
• W1812633805 cites W2079712927 @default.
• W1812633805 cites W2080547984 @default.
• W1812633805 cites W2105665234 @default.
• W1812633805 cites W2137116971 @default.
• W1812633805 cites W2138040883 @default.
• W1812633805 cites W2139054312 @default.
• W1812633805 cites W2146362494 @default.
• W1812633805 cites W2161245921 @default.
• W1812633805 cites W2162453125 @default.
• W1812633805 cites W2165108766 @default.
• W1812633805 cites W2169160058 @default.
• W1812633805 doi "https://doi.org/10.1155/2000/587957" @default.
• W1812633805 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10700672" @default.
• W1812633805 hasPublicationYear "2000" @default.
• W1812633805 type Work @default.
• W1812633805 sameAs 1812633805 @default.
• W1812633805 citedByCount "62" @default.
• W1812633805 countsByYear W18126338052012 @default.
• W1812633805 countsByYear W18126338052013 @default.
• W1812633805 countsByYear W18126338052014 @default.
• W1812633805 countsByYear W18126338052015 @default.
• W1812633805 countsByYear W18126338052016 @default.
• W1812633805 countsByYear W18126338052017 @default.
• W1812633805 countsByYear W18126338052019 @default.
• W1812633805 countsByYear W18126338052022 @default.
• W1812633805 crossrefType "journal-article" @default.
• W1812633805 hasAuthorship W1812633805A5017557589 @default.
• W1812633805 hasAuthorship W1812633805A5021494931 @default.
• W1812633805 hasAuthorship W1812633805A5023864226 @default.
• W1812633805 hasAuthorship W1812633805A5036399848 @default.
• W1812633805 hasAuthorship W1812633805A5040448604 @default.
• W1812633805 hasAuthorship W1812633805A5044898446 @default.
• W1812633805 hasAuthorship W1812633805A5054976871 @default.
• W1812633805 hasAuthorship W1812633805A5072289497 @default.
• W1812633805 hasAuthorship W1812633805A5078128974 @default.
• W1812633805 hasBestOaLocation W18126338051 @default.
• W1812633805 hasConcept C118552586 @default.
• W1812633805 hasConcept C126322002 @default.
• W1812633805 hasConcept C168563851 @default.
• W1812633805 hasConcept C194828623 @default.
• W1812633805 hasConcept C2776042228 @default.
• W1812633805 hasConcept C2776136866 @default.
• W1812633805 hasConcept C2777014857 @default.
• W1812633805 hasConcept C2778720950 @default.
• W1812633805 hasConcept C2780724011 @default.
• W1812633805 hasConcept C2908647359 @default.
• W1812633805 hasConcept C42219234 @default.
• W1812633805 hasConcept C71924100 @default.
• W1812633805 hasConcept C99454951 @default.
• W1812633805 hasConceptScore W1812633805C118552586 @default.
• W1812633805 hasConceptScore W1812633805C126322002 @default.
• W1812633805 hasConceptScore W1812633805C168563851 @default.
• W1812633805 hasConceptScore W1812633805C194828623 @default.
• W1812633805 hasConceptScore W1812633805C2776042228 @default.
• W1812633805 hasConceptScore W1812633805C2776136866 @default.
• W1812633805 hasConceptScore W1812633805C2777014857 @default.
• W1812633805 hasConceptScore W1812633805C2778720950 @default.
• W1812633805 hasConceptScore W1812633805C2780724011 @default.
• W1812633805 hasConceptScore W1812633805C2908647359 @default.
• W1812633805 hasConceptScore W1812633805C42219234 @default.
• W1812633805 hasConceptScore W1812633805C71924100 @default.
• W1812633805 hasConceptScore W1812633805C99454951 @default.
• W1812633805 hasIssue "1" @default.
• W1812633805 hasLocation W18126338051 @default.
• W1812633805 hasLocation W18126338052 @default.
• W1812633805 hasOpenAccess W1812633805 @default.
• W1812633805 hasPrimaryLocation W18126338051 @default.
• W1812633805 hasRelatedWork W1673187729 @default.
• W1812633805 hasRelatedWork W1957770986 @default.
• W1812633805 hasRelatedWork W1985426726 @default.
• W1812633805 hasRelatedWork W2007725130 @default.

• next